Generics 53

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dobutamine manufacturers

53 products found

Filters

53 products found

dobutamine

Solution for infusion 250 mg - 20 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq
Manufacturer #17659
It was established in the 1970s as the result of an industrial initiative targeted at the production of injectable pharmaceuticals in the form of solutions, suspensions, and powders. It works with several Italian and international universities to research and develop novel manufacturing methods for the generic medication market. The company has advanced laboratories for chemical, physical, and microbiological controls to assist production.

Manufacturer usually replies in 8 days

dobutamine

Vials, injection 250 mg/20 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17477
A pharmaceutical manufacturer based in the EU that has partnerships with global pharmaceutical companies worldwide for 90+ years. The company's main therapeutic areas include anesthesia, cardiology, and infectivology. The manufacturing facilities are GMP approved and its activities for FDF and API are FDA approved.

Manufacturer usually replies in 7 days

dobutamine

Solution for injection 250 mg/20 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
Italy
Manufacturer #15048

It offers practical and adaptable solutions for the rapid and cost-effective development of APIs and formulations. Pharmaceutical formulations might be a generic, generic plus, or wholly novel and patented. Original chemicals and medical devices are also being developed by the business.

Manufacturer usually replies in 5 days

dobutamine

Powder for solution for infusion 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #19992
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products for 190+ years. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are GMP-compliant. Main therapy areas include anti-infectives, dermatology, and CNS. The company products are prepared in CTD dossier format.

Manufacturer usually replies in 6 days

dobutamine

Solution for infusion 125 mg/250 ml, 250 mg/250 ml, 500 mg/250 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #298

Manufacturer usually replies in 5 days

dobutamine

Concentrate for solution for infusion 250 mg/20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Angola , Bahrain , Bulgaria , Cameroon , Colombia , Egypt , Ghana , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Lithuania , Morocco , Nigeria , Oman , Qatar , Saudi Arabia , Senegal , South Africa , Sudan , Syria , Tunisia , United Arab Emirates , Vietnam , Yemen
Manufacturer #686
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, CIS, North America, LATAM, Africa, and Asia for 30+ years. The key production line is Rx. Main therapeutic areas include antibiotics, neurology, and cardiovascular. The main dosage form is injectable. The company's production lines are GMP-compliant. The company possesses different production lines in the EU.

Manufacturer usually replies in 5 days

dobutamine

Ampoules, injection 250 mg/20 ml - 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

dobutamine

Vials, injection 50 mg/4 ml, 250 mg/20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

dobutamine

Vials, injection 50 mg/ml, 250mg/20ml - 20 ml, 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

dobutamine

Injection 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20700

Manufacturer usually replies in 5 days

dobutamine + ascorbic acid

Injection 250 mg + 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20656

Manufacturer usually replies in 2 days

dobutamine

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19540

Manufacturer usually replies in 4 days

dobutamine

Solution for injection 250mg/5ml

Dossier type
CTD
Dossier status
Under development
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17805

Manufacturer usually replies in 2 days

dobutamine

Injection 50 mg/ml - 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
ID
Manufacturer #20982

Manufacturer usually replies in 9 days

dobutamine

Vials 12.5 mg/ml - 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

dobutamine

Injection 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #20956
It is specialized in the human healthcare field, and has been manufacturing, marketing, and selling pharmaceutical products since the 1980s. They have a broad range of products from OTC, ETC including about 30 kinds of anti-cancer products.

Manufacturer usually replies in 8 days

dobutamine

Ampoules, injection 250 mg - 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16970
They are a leading pharmaceutical company in the manufacture and marketing of drugs for hospital and outpatient use for human health care. With an extensive history of more than 80 years, the company affirms its commitment to health on a day-to-day basis, producing pharmaceutical products of excellent quality, broad production support, and available to the entire community.

Manufacturer usually replies in 7 days

dobutamine

Ampoules, injection 250 mg - 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16970
They are a leading pharmaceutical company in the manufacture and marketing of drugs for hospital and outpatient use for human health care. With an extensive history of more than 80 years, the company affirms its commitment to health on a day-to-day basis, producing pharmaceutical products of excellent quality, broad production support, and available to the entire community.

Manufacturer usually replies in 7 days

dobutamine

Injection 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

dobutamine

Injection 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20159

Manufacturer usually replies in 10 days

Want to view all 53 products? Create your free account today!

Dobutamine

Dobutamine is used to treat cardiogenic shock and severe heart failure and in certain types of cardiac stress tests. Dobutamine is more effective in the treatment of acute but potentially reversible heart failure, which may occur during cardiac surgery or in cases of septic or cardiogenic shock. Dobutamine can also be used in congestive heart failure to improve cardiac output. Dobutamine is specifically for parenteral therapy when it is necessary for inotropic support in the short-term treatment of cardiac decompensation resulting from depressed contractility. This depressed contractility is caused by organic heart disease or surgical cardiac procedures. However, it is not useful in treating ischemic heart disease. It improves heart rate, eventually resulting in the improvement of myocardial oxygen demand. It is also used in hospitals as a pharmacologic stress testing agent in the identification of coronary artery disease. Dobutamine is sold under the brand names like Dobutrex and Inotrex amongst others Eli Lilly scientists, Drs. Ronald Tuttle and Jack Mills, first developed it in the 1970s, as a structural analog of isoprenaline. Dobutamine received FDA approval for medical use in the United States in 1978. It is a generic medication and made from isoproterenol.

Dosage and administration

Dobutamine is available as an injection of 12.5 mg/mL. Each 20 mL Single-Dose Vials has 250 mg of dobutamine hydrochloride or 40 mL Single-Dose Vials which have 500 mg of Dobutamine hydrochloride. It is injected into the vein as a continuous infusion and the amount of medication needed is adjusted for the desired effect. It acts quickly and the onset of action can be felt within 2 minutes. For preparing the injection, Dilute the 20 mL vial in an IV container in at least 50 mL of diluent and dilute 40 mL in at least 100 mL of diluent. The intravenous solutions are diluted with Dextrose Injection 5%, Dextrose 5%, and Sodium Chloride 0.9% Injection, Dextrose Injection 10%, Lactated Ringer's Injection, 5% Dextrose in Lactated Ringer's Injection, in Water for Injection. The infusion of dosage recommended for cardiac output improvement is between 2.5 to 15 mcg per kilo per minute. This can be raised to 40mcg is the desired effect is not achieved at the regular dose.

The cost of Dobutamine

In the UAS, the consumer pay around $92 for a supply of 3000 milliliters of Dobutamine intravenous solution 1 mg/mL-D5%. This medicine is more affordable in the developing world. In India, the consumer pay around $2 for a supply of 5 vials of 5ml totaling 250mg milliliters of Dobutamine intravenous solution 1 mg/mL-D5%.

How does Dobutamine Work?

Dobutamine is a direct-acting inotropic agent. Its primary actions caused by stimulating beta- adrenoceptors in the heart where it creates relatively mild chronotropic, hypertensive, arrhythmogenic, and vasodilative effects. Dobutamine targets beta-1 adrenergic receptors while having negligible effects on beta-2 receptors. Unlike dopamine, It does not release endogenous norepinephrine. Dobutamine actions by stimulating the beta-1 receptors, increase myocardial contractility, and stroke volume. The final result is an increased cardiac output.

Finding Dobutamine Manufacturers and Suppliers:

The process of finding trusted Dobutamine manufacturers and Dobutamine suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B a marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is easy to use an online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Dobutamine. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.